Business News • PR NewsWire • Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

PHILADELPHIA and LONDON, Nov. 3, 2010 /PRNewswire/ -- Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR

View More : http://www.prnewswire.com/news-releases/asia-pacific-pharma-companies-turning-to-high-risk-high-reward-drug-development-...

Releted News by prnewswire

Major Study Reveals that Private Equity's Center of Gravity is Shifting Toward Emerging Markets as Returns in these Markets Accelerate

Verizon Business Earns Telemark's 'World-Class' Ranking Among Information Communications Technology Providers